CoChat

High‐throughput T‐cell receptor sequencing across chronic liver diseases reveals distinct disease‐associated repertoires

Open access
Liaskou, Evaggelia, Henriksen, Eva Kristine Klemsdal, Holm, Kristian, Kaveh, Fatemeh, Hamm, David, Fear, Janine, Viken, Marte K., Hov, Johannes Roksund, Melum, Espen, Robins, Harlan, Olweus, Johanna, Karlsen, Tom H., Hirschfield, Gideon M. · 2016 · Hepatology
Cited by 83

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

Hepatic T‐cell infiltrates and a strong genetic human leukocyte antigen association represent characteristic features of various immune‐mediated liver diseases. Conceptually the presence of disease‐associated antigens is predicted to be reflected in T‐cell receptor (TCR) repertoires. Here, we aimed to determine if disease‐associated TCRs could be identified in the nonviral chronic liver diseases primary biliary cirrhosis (PBC), primary sclerosing cholangitis (PSC), and alcoholic liver disease (ALD). We performed high‐throughput sequencing of the TCRβ chain complementarity‐determining region 3 of liver‐infiltrating T cells from PSC (n = 20), PBC (n = 10), and ALD (n = 10) patients, alongside genomic human leukocyte antigen typing. The frequency of TCRβ nucleotide sequences was significantly higher in PSC samples (2.53 ± 0.80, mean ± standard error of the mean) compared to PBC samples (1.13 ± 0.17, P < 0.0001) and ALD samples (0.62 ± 0.10, P < 0.0001). An average clonotype overlap of 0.85% was detected among PSC samples, significantly higher compared to the average overlap of 0.77% seen within the PBC (P = 0.024) and ALD groups (0.40%, P < 0.0001). From eight to 42 clonotypes were uniquely detected in each of the three disease groups (≥30% of the respective patient samples). Multiple, unique sequences using different variable family genes encoded the same amino acid clonotypes, providing additional support for antigen‐driven selection. In PSC and PBC, disease‐associated clonotypes were detected among patients with human leukocyte antigen susceptibility alleles. Conclusion: We demonstrate liver‐infiltrating disease–associated clonotypes in all three diseases evaluated, and evidence for antigen‐driven clonal expansions. Our findings indicate that differential TCR signatures, as determined by high‐throughput sequencing, may represent an imprint of distinctive antigenic repertoires present in the different chronic liver diseases; this thereby opens up the prospect of studying disease‐relevant T cells in order to better understand and treat liver disease. (H epatology 2016;63:1608‐1619)

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/hep.28116

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Research works printed but not linked: 20

  1. 1981, Morphologic features of chronic hepatitis associated with primary sclerosing cholangitis and chronic ulcerative colitis, Hepatology, 1, 632, 10.1002/hep.1840010612 · DOI · Paper page
  2. 2014, Loss of CD28 expression by liver‐infiltrating T cells contributes to pathogenesis of primary sclerosing cholangitis, Gastroenterology, 147, 221, 10.1053/j.gastro.2014.04.003 · DOI · Paper page
  3. 2013, Increased T helper type 17 response to pathogen stimulation in patients with primary sclerosing cholangitis, Hepatology, 58, 1084, 10.1002/hep.26447 · DOI · Paper page
  4. 2014, Reduced FOXP3+ regulatory T cells in patients with primary sclerosing cholangitis are associated with IL2RA gene polymorphisms, J Hepatol, 60, 1010, 10.1016/j.jhep.2013.12.027 · DOI
  5. 2002, Lymphocyte recruitment to the liver in alcoholic liver disease, Alcohol, 27, 29, 10.1016/S0741-8329(02)00208-2 · DOI
  6. 2011, Electrostatic modifications of the human leukocyte antigen‐DR P9 peptide‐binding pocket and susceptibility to primary sclerosing cholangitis, Hepatology, 53, 1967, 10.1002/hep.24299 · DOI · Paper page
  7. 2014, Refinement of the MHC risk map in a scandinavian primary sclerosing cholangitis population, PLoS One, 9, e114486, 10.1371/journal.pone.0114486 · DOI
  8. 2015, Association between HLA haplotypes and increased serum levels of IgG4 in patients with primary sclerosing cholangitis, Gastroenterology, 148, 924, 10.1053/j.gastro.2015.01.041 · DOI · Paper page
  9. 1995, T‐cell repertoire diversity and clonal expansions in normal and clinical samples, Immunol Today, 16, 176, 10.1016/0167-5699(95)80117-0 · DOI · Paper page
  10. 2003, Application of the molecular analysis of the T‐cell receptor repertoire in the study of immune‐mediated hematologic diseases, Hematology, 8, 173, 10.1080/1024533031000107505 · DOI
  11. 2013, BRAF inhibition is associated with increased clonality in tumor‐infiltrating lymphocytes, Oncoimmunology, 2, e26615, 10.4161/onci.26615 · DOI · Paper page
  12. 2000, Skewed T‐cell receptor variable gene usage in the synovium of early and chronic rheumatoid arthritis patients and persistence of clonally expanded T cells in a chronic patient, Rheumatology (Oxford), 39, 1189, 10.1093/rheumatology/39.11.1189 · doi:10.1093/rheumatology/39.11.1189
  13. 1995, Heterogeneity of autoreactive T cell clones specific for the E2 component of the pyruvate dehydrogenase complex in primary biliary cirrhosis, J Exp Med, 181, 723, 10.1084/jem.181.2.723 · DOI · Paper page
  14. 2002, Identification of HLA‐A2‐restricted CD8+ cytotoxic T cell responses in primary biliary cirrhosis: T cell activation is augmented by immune complexes cross‐presented by dendritic cells, J Exp Med, 195, 113, 10.1084/jem.20010956 · DOI · Paper page
  15. 1997, Preferential V beta3 usage by hepatic T lymphocytes in patients with primary sclerosing cholangitis, J Hepatol, 26, 527, 10.1016/S0168-8278(97)80417-5 · DOI
  16. 1997, Analysis of human common bile duct–associated T cells: evidence for oligoclonality, T cell clonal persistence, and epithelial cell recognition, J Immunol, 158, 1941, 10.4049/jimmunol.158.4.1941 · DOI
  17. 2004, Mechanisms of alcohol liver damage: aldehydes, scavenger receptors, and autoimmunity, Front Biosci, 9, 3145, 10.2741/1467 · DOI
  18. 2001, Alcoholic liver disease: new insights into mechanisms and preventative strategies, Trends Mol Med, 7, 408, 10.1016/S1471-4914(01)02096-2 · DOI · Paper page
  19. 1993, Gliadin‐specific, HLA‐DQ(alpha 1*0501,beta 1*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients, J Exp Med, 178, 187, 10.1084/jem.178.1.187 · DOI · Paper page
  20. 2014, Tetramer‐visualized gluten‐specific CD4+ T cells in blood as a potential diagnostic marker for coeliac disease without oral gluten challenge, United European Gastroenterol J, 2, 268, 10.1177/2050640614540154 · DOI · Paper page

Cited by

Metadata

Authors
Liaskou, E., Henriksen, E. K. K., Holm, K., Kaveh, F., Hamm, D., Fear, J., Viken, M. K., Hov, J. R., Melum, E., Robins, H., Olweus, J., Karlsen, T. H., & Hirschfield, G. M.
Venue
Hepatology
Published
2015-09-30
Volume
63
Issue
5
Pages
1608-1619
ISSN
  • 0270-9139 (ISSN-L)
  • 1527-3350
OpenAlex
W1780260732
Cited by
83
References
6
FWCI
4.78
Type
journal article
Language
en
Open access
bronze
Licence
doi.wiley.com/10.1002/tdm_license_1.1 (tdm)
Funders
  • Norwegian PSC Research Center
  • National Institute for Health Research (NIHR)
  • PSC Partners Seeking a Cure

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.